Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and PK of Intranasal Olcegepant in Healthy Volunteers
NCT02198326Phase 1Completed
- Sponsor
- Boehringer Ingelheim
- Start
- Jul 1999
- Primary completion
- Aug 1999
- Modality
- Small Molecules
01
Overview
Phase 1, randomised, double-blind trial in migraine comparing BIBN 4096 BS with Placebo (2 arms). Primary endpoints: Changes in nasal mucosa assessed by rhinoscopy, Changes in nasal flow and resistance assessed by rhinomanometry and 1 more. Started Jul 1999; status: completed.
02
Drugs
olcegepant
03
Conditions
migraine
Beyond the preview
Go deeper on NCT02198326.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02198326.